These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902 [TBL] [Abstract][Full Text] [Related]
9. Haloperidol-Induced Preclinical Tardive Dyskinesia Model in Rats. Guzen FP; Cavalcanti JRLP; Cavalcanti DMLP; de Sales LGP; da Silva MSM; da Silva ANA; Pinheiro FI; de Araújo DP Curr Protoc Neurosci; 2019 Jun; 88(1):e68. PubMed ID: 31216395 [TBL] [Abstract][Full Text] [Related]
10. Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia. Syu A; Ishiguro H; Inada T; Horiuchi Y; Tanaka S; Ishikawa M; Arai M; Itokawa M; Niizato K; Iritani S; Ozaki N; Takahashi M; Kakita A; Takahashi H; Nawa H; Keino-Masu K; Arikawa-Hirasawa E; Arinami T Neuropsychopharmacology; 2010 Apr; 35(5):1155-64. PubMed ID: 20072119 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol. Kajero JA; Seedat S; Ohaeri J; Akindele A; Aina O World J Biol Psychiatry; 2020 Oct; 21(8):612-626. PubMed ID: 32264772 [No Abstract] [Full Text] [Related]
14. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation. An HM; Tan YL; Shi J; Wang Z; Lv MH; Soares JC; Zhou D; Yang F; Zhang XY Phytomedicine; 2016 Dec; 23(13):1653-1660. PubMed ID: 27823630 [TBL] [Abstract][Full Text] [Related]
15. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats. Haleem DJ; Samad N; Haleem MA Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786 [TBL] [Abstract][Full Text] [Related]
16. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice. Crowley JJ; Kim Y; Szatkiewicz JP; Pratt AL; Quackenbush CR; Adkins DE; van den Oord E; Bogue MA; Yang H; Wang W; Threadgill DW; de Villena FP; McLeod HL; Sullivan PF Mamm Genome; 2012 Jun; 23(5-6):322-35. PubMed ID: 22207321 [TBL] [Abstract][Full Text] [Related]
18. Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias. Konitsiotis S; Tsironis C; Kiortsis DN; Evangelou A Psychopharmacology (Berl); 2006 Apr; 185(3):369-77. PubMed ID: 16518645 [TBL] [Abstract][Full Text] [Related]
19. Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals. Patil R; Hiray Y; Shinde S; Langade P Pharm Biol; 2012 Jun; 50(6):691-7. PubMed ID: 22136413 [TBL] [Abstract][Full Text] [Related]
20. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats. Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]